Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO

To study the effect of resistance exercises on blood glucose level (HbA1C) in patients with type 2 Diabetes Mellitus coming to rural health setup

1 Patients willing to participate 

2 Patients diagnosed with type 2 DM with HbA1C≥ 6.4

3 BMI ≥ 23 kg/m2

4 Patient able to perform 10RM using weight cuff

5 Patients hand grade 3 in MMT

EXCLUSION CRITERIA 

   1 Elevated BP (resting BP> 200/115)

   2 Cardiac disorders such as coronary artery disease, atrial fibrillation.

   3 Respiratory disorders .

   4 Patient not willing to participate

   5 Orthopaedic Abnormalities

 Exercise Protocol will be of 40 Minutes. 

Subjects will be undergoing the exercise session for 40 min for 3days per week for the period of 4 weeks.

The exercise regimen will be consisted of  5mins  warm up session which included  brisk walking , curl ups, neck rotations and gentle stretching. 

30 min intervention phase 

Upper limb and lower limb patterns was administered in standing, resistance was given through weight cuff (weights cuff were selected ranging from least resistance i.e 0.5 kg to 2kg.) based on 10 RM

According To FITT Principle -

F -  3days /week (alternate days alternate muscle group )

I-   moderate intensity 40% to 60% of 10 RM

T-  30 min 

T-  weight cuff 

Upper Limb Muscles -        

1. TRAPEZIUS

2.BICEPS 

3.TRICEPS 

4.PECTORALS  MAJOR

       Lower Limb Muscles -

1. QUADRICEPS 

2.HAMSTRINGS

3.CALF 

4. GLUTEI  

   

COOL DOWN PHASE 

STRECHINGS FOR THE SAME MUSCLES WILL BE GIVEN 

The Data collected will be analyzed by various statistical methods mean, median and test of significance, The data will be analyzed with IBM SPSS 25 for windows statistical software. For all statistical analyses, probability levels of P < 0.05 will be considered statistically significant

STUDY PERIOD  6 Months

 AMENDMENT OF PROTOCOL

No change in the study procedure shall be affected without the mutual agreement of investigator, physician and ethical committee

     The identity of patient generated in the study will be bounded in strict confidence. The remaining data will be available only to the investigator involved in the study and to the regulatory authorities. Break in the confidentiality is possible only after detail review by the investigator and with the permission of the ethical committee. Information will be disclosed to the concerned person/authority under special circumstances like severe unreported untoward reactions.